← FDA DRUG APPROVALS

FDA ANDA · ANDA062648

ERYC 125

Sponsor: PARKE DAVIS

APPLICATION
ANDA062648
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED REL PELLETS
MARKETING STATUS
Discontinued

Products

ERYC 125Discontinued
ERYTHROMYCIN 125MG · CAPSULE, DELAYED REL PELLETS · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →